Treatment of Cystoid Macular Edema Related to Retinitis Pigmentosa with Intravitreal Triamcinolone Acetonide: Case Report
Cystoid macular edema is an important cause of central visual loss in patients suffering from retinitis pigmentosa (Weleber et al., 2001). A few treatment modalities have been described, including the use of carbonic anhydrase inhibitors and grid laser photocoagulation (Fetkenhour et al., 1977).
Although intravitreal triamcinolone acetonide has been successfully employed to treat macular edema related to several diseases, no previous reports have described its use in retinitis pigmentosa complicated by cystoid macular edema.
Unable to display preview. Download preview PDF.
- Fetkenhour CL, Choromokos E, Weinstein J et al., 1977, Cystoid macular edema in retinitis pigmentosa. Trans Am Acad Ophthalmol Otolaryngol. 83:515–21.Google Scholar
- Vinores SA, Kuchle M, Derevjanik NL, Henderer JD, Mahlow J, Green WR, Campochiaro PA., 1995, Blood-retinal barrier breakdown in retinitis pigmentosa: light and electron microscopic immunolocalization. Histol Histopathol. 10:913–23.Google Scholar
- Weleber RG, Gregory-Evans K, Retinitis Pigmentosa and Allied Disorders, 2001, In Ryan, SJ: Retina, 3rd Edition, Volume 1, St Louis, Mosby, 362–460.Google Scholar